Incidence of Squamous Cell Carcinoma of the Anus Increasing
There has been an increase in the incidence of squamous cell carcinoma of the anus in the United States.
Skin Cancer
Pembrolizumab Prolongs Survival in Advanced Head, Neck Cancer
The checkpoint inhibitor pembrolizumab prolongs survival in patients with certain head and neck cancers.
Invasive Melanoma Incidence Decreasing in Teens, Young Adults
Melanoma incidence seems to be decreasing in adolescents and young adults.
Mechanical Stress May Play a Role in Plantar Melanoma
Weightbearing areas indicating mechanical stress are correlated with a higher number of plantar melanoma and also show a tendency to manifest as invasive melanomas at diagnosis more frequently than in non-weightbearing areas.
Use of Artificial Intelligence on Camera-Based Images of Skin Lesions Shows Promise in the Diagnosis of Melanoma
Researchers investigated the use of artificial intelligence to evaluate skin lesions suspicious for melanoma in camera-based images as a potential decision-support tool.
Indoor Tanning Linked to Increased Cutaneous Squamous Cell Carcinoma Risk in Women
The association between cumulative exposure to indoor tanning and the risk for cutaneous squamous cell carcinoma did not vary regardless of age at initiation and duration of use.
Soluble PD-1 Is a Potential Biomarker in Metastatic Melanoma in Patients Treated With Autologous Vaccines
A small study on patients with metastatic melanoma who were treated with autologous vaccines in a phase 2 clinical trial suggests that soluble PD-1 may have potential as a prognostic biomarker.
Bariatric Surgery Linked to Reduced Risk for Skin Cancer
For individuals with obesity, bariatric surgery is associated with a reduced risk for skin cancer, including melanoma.
Expert Second Opinions Improve Reliability of Melanoma Diagnosis
Second opinions rendered by dermatopathologists improve the reliability of melanocytic lesion diagnosis, although there is still discordance among pathologists.
Nivolumab Regimens Offer Greater Survival in Patients With Advanced Melanoma
In patients with advanced melanoma, sustained long-term overall survival at 5 years was greater in patients who received nivolumab plus ipilimumab or nivolumab alone than in those who received only ipilimumab.
Next post in Skin Cancer
